Adherence to Guidelines for ESRD Anemia Management
- 31 March 2006
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 47 (3), 455-461
- https://doi.org/10.1053/j.ajkd.2005.11.012
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Epoetin requirements predict mortality in hemodialysis patientsAmerican Journal of Kidney Diseases, 2004
- Pure Red-Cell Aplasia and Epoetin TherapyNew England Journal of Medicine, 2004
- The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patientsKidney International, 2003
- Switching from i.v. to s.c. epoetin in hemodialysis patients.American Journal of Health-System Pharmacy, 2002
- Preaching and practice: evidence-based medicine and the accountability of nephrologists within the health care system. The implications of the findings of the cost-saving potential of subcutaneous versus intravenous epoetin therapy.American Journal of Kidney Diseases, 2002
- Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patientsAmerican Journal of Kidney Diseases, 2002
- Once-weekly compared with three-times-weekly subcutaneous epoetin β: Results from a randomized, multicenter, therapeutic-equivalence studyAmerican Journal of Kidney Diseases, 2002
- Erythropoietin for End-Stage Renal DiseaseNew England Journal of Medicine, 1998
- Subcutaneous Compared with Intravenous Epoetin in Patients Receiving HemodialysisNew England Journal of Medicine, 1998
- Comparison of dose requirement, serum erythropoietin and blood pressure following intravenous and subcutaneous erythropoietin treatment of dialysis patientsEuropean Journal of Clinical Pharmacology, 1996